Results

Total Results: 951 records

Showing results for "death".

  1. effectivehealthcare.ahrq.gov/sites/default/files/related_files/assessing-applicability-quiz.ppt
    May 29, 2025 - Why might the use of a composite end point (e.g., death, nonfatal myocardial infarction, ventricular … Composite End Points Effects of Composite End Points Why might the use of a composite end point (e.g., death
  2. effectivehealthcare.ahrq.gov/sites/default/files/assessing-applicability-quiz.ppt
    May 29, 2025 - Why might the use of a composite end point (e.g., death, nonfatal myocardial infarction, ventricular … Composite End Points Effects of Composite End Points Why might the use of a composite end point (e.g., death
  3. effectivehealthcare.ahrq.gov/sites/default/files/tx-for-localized-prostate-cancer_surveillanceassesment_20120614.pdf
    May 01, 2012 - Six months of combination therapy reduced clinical failure, biochemical failure, or death from any … the two, or orchiectomy with diabetes, coronary heart disease, myocardial infarction, sudden cardiacdeath, or stroke. … associated with increased risk of diabetes, coronary heart disease, myocardial infarction, sudden cardiacdeath, and stroke.
  4. effectivehealthcare.ahrq.gov/sites/default/files/related_files/tx-for-localized-prostate-cancer_surveillanceassesment_20120614.pdf
    May 01, 2012 - Six months of combination therapy reduced clinical failure, biochemical failure, or death from any … the two, or orchiectomy with diabetes, coronary heart disease, myocardial infarction, sudden cardiacdeath, or stroke. … associated with increased risk of diabetes, coronary heart disease, myocardial infarction, sudden cardiacdeath, and stroke.
  5. effectivehealthcare.ahrq.gov/sites/default/files/sadwin.pdf
    January 01, 2011 - Partnering with Patients to Disseminate Research Products …
  6. effectivehealthcare.ahrq.gov/sites/default/files/related_files/version-3-immunity-after-COVID-19-appendix-table-B-1.xlsx
    January 24, 2022 - proxy for severe, and ICU admission as a proxy for critical COVID-19 (Table 1 footnotes) COVID-19 death … was defined per WHO classification as "a death resulting from a clinically compatible illness, in a … probable or confirmed COVID-19 case, unless there is a clear alternative cause of death that cannot be … against any reinfection, symptomatic reinfection, and against COVID-19 related hospitalization and death … ; reported as adjusted [a]HR) Nyberg 2022 Comparative analysis of the risks of hospitalisation and death
  7. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0520-131115.pdf
    May 29, 2025 - Despite recent decreases in mortality, heart disease remains the leading cause of death in the US for
  8. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-193-naloxone-executive-summary.pdf
    November 01, 2017 - opioids has increased four-fold.2,3 Drug overdose deaths are now the leading cause of injury-related death … for injury.16,17 When responding to opioid overdoses, early intervention is critical to prevent death … Although six studies reported low rates (0 to 1.2%) of death or serious adverse events among patients … use disorder and risk of future overdose episodes, in addition to serious adverse outcomes such as death … Rates of opioid pain reliever (OPR) overdose death, OPR treatment admissions, and kilograms of OPR
  9. effectivehealthcare.ahrq.gov/sites/default/files/related_files/angina-heart-attack-treatments_disposition-comments.pdf
    January 01, 2014 - para 2, sentence 3 Event rates are incorrect for ticagrelor and clarification is needed on type of death … Revise to: At 30 days, prasugrel reduced rates of cardiovascular death/myocardial infarction/stroke … Why is SOE insufficient with consistent direct, precise results for death/MI/revasc The strength of … The numbers shown for composite efficacy endpoint at 30 days and 3 months are for CV death/MI/stroke … 30kg/m2: Composite outcome (vascular death, nonfatal MI, or stroke at 30 days 1 year) Major bleeding
  10. effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-ovarian-contraceptives_research-protocol.pdf
    March 13, 2012 - use.12,13 OCs have both other noncontraceptive health benefits14,15 and harms, including premature death … The final outcomes of the model are death from ovarian cancer and death from other causes. … Schematic of Proposed Model Reproductive History Model (see Figure 3) Death from Other Cause … other benign gynecological disorders, acne, and premenstrual dysphoric disorder (PMDD) as well as death … cancer, colorectal cancer) or increase in risk (e.g., breast and cervical cancer, MI, stroke) • Death
  11. effectivehealthcare.ahrq.gov/sites/default/files/related_files/coronary-artery-stenting_disposition-comments.pdf
    February 26, 2013 - evidence suggests that the use of FFR reduced the rate of target lesion revascularization, but not MI or death … : mention should be made that the primary and point of the same trial was the composite outcome of death … We have amended the text to indicate that the primary endpoint was death, MI, and repeat revascularization … The DEFER study demonstrated that the risk of cardiac death or myocardial infarction related to a functionally … The purpose of FAME II is to compare the clinical outcomes (a composite of all cause death, documented
  12. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cad-pci-bypass_addendum.pdf
    February 01, 2010 - The composite endpoint of death or myocardial infarction within 90 days, which could be assessed in … The composite outcome of death or repeat revascularization was significantly lower (p<0.0001) in patients … from the SYNTAX trial,32 which showed no significant difference in the combined endpoint of 6 death … Data show overall unadjusted mortality (A) and composite endpoint of death or myocardial infarction ( … Data on death with myocardial infarction were not available from the Emory Angioplasty versus Surgery
  13. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-263-postpartum-hypertensive-pregnancy-executive-summary.pdf
    May 01, 2023 - evidence regarding the effect of different MgSO4 regimens on serious clinical outcomes (seizures, death … MgSO4 regimens probably increase the risk of recurrent seizures (Moderate SoE) but not the risk of death
  14. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cell-free-dna-executive-summary.pdf
    May 01, 2025 - asked several Contextual Questions about the relationship between finding advanced cancers and cancer death
  15. effectivehealthcare.ahrq.gov/sites/default/files/pdf/heart-failure-transition-care_policymaker.pdf
    August 01, 2016 - readmissions, HF- specific readmissions, the composite endpoint (which comprises all-cause readmission or death … significant and that an NNT was not calculated. ** The composite endpoint comprises all-cause readmission or death
  16. effectivehealthcare.ahrq.gov/sites/default/files/breast-reconstruction-mastectomy-protocol-appendix-a.pdf
    May 29, 2025 - or injurious or serious or fatal) AND (effect* or reaction* or event* or outcome* or incident*)) OR death
  17. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0407_01-20-2011.pdf
    January 01, 2011 - Does aspirin reduce the risk of adverse cardiovascular events (MI, stroke, cardiovascular death) in
  18. effectivehealthcare.ahrq.gov/sites/default/files/pdf/ace-inhibitor-arb-2007_research-2007-1.pdf
    January 01, 2007 - In addition to being the number one attributable risk factor for death throughout the world, hypertension … In particular, there is a lack of information about death or major cardiovascular events, and data on … billion individuals, and suboptimal blood pressure is the number one attributable risk factor for death … Reduction in risk of MI, stroke, and death from cardiovascular causes for patients 55 years or older … Used to decrease risk of death and heart failure-related hospitalization.
  19. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/atrial-fibrillation-ablation_executive.pdf
    July 01, 2009 - anti-arrhythmic drugs (AADs) was associated with a worse outcome, including an increased risk of all-cause death … over time, the presence of sinus rhythm was associated with a considerable reduction in the risk of death … (Three publications from the same group of investigators each reported one death from atrioesophageal … of AF, and no randomized trial has examined the effect of catheter ablation on the risk of stroke or death … To fully comprehend outcomes like stroke, death, or quality of life, much longer followup will be needed
  20. effectivehealthcare.ahrq.gov/sites/default/files/related_files/ptsd-pharm-non-pharm-treatment-update-disposition-comments.pdf
    August 28, 2024 - report where suicide is mentioned, it would be helpful if there is a distinction made between suicide death … We have changed Suicide Completion to Suicide Death for corresponding variables. … Discussion and Conclusion P47 line 39—please update language/replace “suicide completion” with “suicide death … ” or “death by suicide” We have made this change throughout the report and in the evidence tables

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: